SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001328143-19-000019
Filing Date
2019-04-25
Accepted
2019-04-25 16:03:22
Documents
5
Period of Report
2019-06-05
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A adms2019proxystatement.htm DEF 14A 542642
2 cardpg1.jpg GRAPHIC 774457
3 cardpg2.jpg GRAPHIC 632182
4 proxyadmslogo.jpg GRAPHIC 3700
5 wentsignature.jpg GRAPHIC 19006
  Complete submission text file 0001328143-19-000019.txt   2511273
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36399 | Film No.: 19767404
SIC: 2834 Pharmaceutical Preparations